Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer

Abstract Background Bladder cancer (BC) is one of the most common malignant diseases and the most common causes of cancer death worldwide. Immunotherapy has opened new avenues for precision treatment of bladder tumours, and immune checkpoint inhibitors (ICIs) have revolutionized the clinical treatme...

Full description

Bibliographic Details
Main Authors: Pengyu Hui, Feng Ni, Liang Zheng, Lei Jia, Zhe Wang
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Cancer
Subjects:
Bladder cancer
Immunotherapy
Long non-coding RNA
Prognostic
ceRNA network
Molecular docking
Online Access:https://doi.org/10.1186/s12885-023-10828-z

Similar Items

Similar Items